Esayas Kebede Gudina
Esayas Kebede Gudina is an expert in Infectiology at Jimma University (Ethiopia). As of May 2026, ScienceLeadR ranks Esayas Kebede Gudina in the top 1% of experts in Ethiopia for Cardiomyopathies, COVID-19 and Epidemiologic Studies. Esayas Kebede Gudina has authored 134 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 4 of them ongoing. SLR score: 488 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Hepatology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 134
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Quality of life, stigma, and mental health, in individuals affected by leprosy: a cross-sectional study. PMID 42206721 — depression, leprosy, quality of life, hygiene, cross-sectional studies, sleep, education, mental health | Trans R Soc Trop Med Hyg | 2026 | 0 |
| Dynamics and variant-specific patterns of SARS-CoV-2 reinfection in Ethiopia: a prospective longitudinal cohort study. PMID 42155666 — sars-cov-2, cohort studies, covid-19, severe acute respiratory syndrome-related coronavirus, communicable diseases, reinfection, infections | Int J Infect Dis | 2026 | 0 |
| A new hepatitis delta virus hotspot in Ethiopia: a multicenter study. PMID 42025746 — hepatitis d, epidemiology, hepatitis delta virus, transaminases, liver, viruses, prevalence, communicable diseases, infections, hepatitis | Int J Infect Dis | 2026 | 0 |
| Group B Streptococcus in African pregnancies: A systematic review and meta-analysis of its maternal rectovaginal colonization, vertical transmission, serotype distribution, and antimicrobial resistance. PMID 42001933 — pregnancy, streptococcus, infant, newborn, infectious disease transmission, vertical, tetracycline, prevalence, trimethoprim, sulfamethoxazole drug combination, communicable diseases | Int J Infect Dis | 2026 | 0 |
| Sepsis-associated myocarditis: Epidemiology, pathophysiology, diagnosis, management, and future directions. PMID 41883741 — mortality, epidemiology, myocarditis, sepsis, diagnosis, research, therapeutics | JRSM Cardiovasc Dis | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Sepsis and Myocarditis NCT07079605 — toxemia, mortality, heart failure, cohort studies, survival analysis, signs and symptoms, myocarditis, sepsis, therapeutics | N/A | Recruiting | 2025 |
| SARS CoV 2 Specific Antibody Responses and Impact for COVID 19 Disease in Ethiopia NCT06435403 — antibody formation, sars-cov-2, epidemiology, longitudinal studies, vaccines, seroepidemiologic studies, vaccination, covid-19, immunity, severe acute respiratory syndrome-related coronavirus, infections | N/A | Recruiting | 2022 |
| Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age NCT06250257 — mesylates, exercise, cardiomyopathy, dilated, sodium-glucose transporter 2 inhibitors, quality of life, ventricular function, left, heart failure, bromocriptine, heart, biomarkers, prolactin, stair climbing, therapeutics, ventricular function, walk test, cardiomyopathies, women | Phase 3 | Recruiting | 2024 |
| Reducing Mortality in Adults With Advanced HIV Disease (REVIVE) NCT05580666 — mortality, pharmaceutical preparations, disease progression, tablets, acquired immunodeficiency syndrome, hiv, viruses, azithromycin, counterfeit drugs, therapeutics | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map